Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Pharmaceuticals
INVESTING
5 Top Stock Gainers for Friday: Novan, Magnachip, Vaxart
By Rob Lenihan
INVESTING
Incyte Sees Delay in FDA Review of Eczema Cream
By Dan Weil
INVESTING
Biogen Analysts Upgrade Stock Amid Alzheimer's Drug Controversy
By Rob Daniel
INVESTING
Vertex Halts Further Study of AATD Drug
By Rob Daniel
INVESTING
Bristol-Myers Higher on Progress With Lymphoma-Drug Trial
By Rob Lenihan
INVESTING
5 Top Stock Gainers for Wednesday: SPI Energy, Checkpoint Therapeutics
By Rob Lenihan
INVESTING
Biden Reportedly to Buy 500 Million Pfizer Shots for Low-Income Nations
By Rob Lenihan
INVESTING
Amazon Reportedly Offering Six-Month Prescriptions for $6
By Dan Weil
INVESTING
Biogen Lifted to Neutral at Bank of America, Baird After FDA Approval
By Dan Weil
INVESTING
5 Top Stock Gainers for Monday: U.S. Concrete, Moderna, Eli Lilly
By Rob Lenihan
INVESTING
Cullinan Gets FDA Investigational Clearance for Leukemia Drug
By Dan Weil
INVESTING
OpGen Rises on Submitting Updated Testing Materials to FDA
By Rob Lenihan
INVESTING
Biogen's Alzheimer's Treatment Is Approved by FDA; Stock Soars
By Rob Lenihan
INVESTING
AstraZeneca Drug Reduces Relapse, Death in Breast Cancer Patients
By Rob Lenihan
INVESTING
Biogen Higher as Investors Await FDA Decision on Alzheimer's Drug
By Dan Weil
INVESTING
5 Top Stock Gainers for Wednesday: AMC, Constellation Pharma, Skillz
By Rob Lenihan
INVESTING
Amgen Rises After Key Lung-Cancer Treatment Cleared by FDA
By Tony Owusu
INVESTING
Syros Pharma Skyrockets on Oppenheimer Buy Rating, Ark Sale
By Rob Lenihan
INVESTING
Lantheus Soars on FDA Approval of Prostate Cancer Identifier
By Rob Lenihan
INVESTING
Travere Drops Quest for Quick FDA Clearance of Kidney-Disease Drug
By Dan Weil
INVESTING
5 Top Stock Gainers for Tuesday: Shake Shack, Moderna, Square
By Rob Lenihan
INVESTING
Provention Higher After FDA Assessment of Drug Study
By Dan Weil
INVESTING
Moderna Study Says Vaccine Works on Teens; FDA Clearance Is Seen
By Dan Weil
INVESTING
NGM Biopharma Down; Ends Development of Liver-Disease Drug
By Dan Weil
